Dr. Vince Clinical Research Presents Groundbreaking Webinar on Accelerating Clinical & Drug Development Timelines with AI

Audio By Carbonatix

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Jul 24, 2024--

Dr. Vince Clinical Research (DVCR), a full-service contract research organization (CRO) specializing in early-phase clinical trials, is pleased to announce " Accelerating Clinical & Drug Development Timelines with AI," an exclusive webinar exploring AI’s significant impact on accelerating drug discovery, streamlining clinical project management, advancing data tabulation and analysis and responsibly utilizing AI for digital endpoint collection. The 60-minute webinar is scheduled for Wednesday, Sept. 11, 2024, at 2:00 p.m. ET and is hosted by Fierce Biotech.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240724236092/en/

Dr. Viswa Colluru, Ph.D., Founder and CEO, Enveda Biosciences (Photo: Business Wire)

Join industry leaders from Enveda Biosciences, Dr. Vince Clinical Research (DVCR), and Clario to cover key learning objectives.

• Dr. Viswa Colluru, Ph.D., Founder and CEO, Enveda Biosciences
• Tony Cardozo, Manager, Statistical Programming, Dr. Vince Clinical Research
• Dr. Todd Rudo, EVP and Chief Medical Officer, Clario
• Beth Williams, Executive Director, Clinical Trial Services, Dr. Vince Clinical Research

Attendees will learn how AI can expedite key deliverables in clinical research. "Harnessing the power of advanced generative AI in Large Language Models can revolutionize drug development by refining processes and accelerating the journey from lab to patient," asserts Bradley Vince, DO, CEO and Chief Medical Officer of DVCR. "AI innovation ensures life changing treatments can reach those in need faster than ever before."

For more details and to register for "Accelerating Clinical & Drug Development Timelines with AI," please visit our website.

About Dr. Vince Clinical Research

Dr. Vince Clinical Research (DVCR) is a full-service contract research organization (CRO) specializing in early phase trials in both healthy normal volunteers and patient populations across a wide range of trial designs and therapeutic areas such as neuroscience, substance abuse, pain, cardiometabolic disorders, infectious diseases and many others. CRO services include project management, data management, biostatistics, statistical programming, PK/PD analysis, medical writing, monitoring as well as site feasibility and management for multi-site trials. Additionally, DVCR operates one of the most innovative and technologically advanced clinical pharmacology units in the world with over 90 beds for overnight confinement, a cGMP compliant pharmacy as well as luxurious amenities to support diverse study participant recruitment and retention. By leveraging technology and one of the country’s most experienced leadership teams in early clinical development, DVCR provides Smarter Faster Data® to their biopharmaceutical clients.

For more information, go to sponsors.drvince.com. Connect with Dr. Vince Clinical Research on LinkedIn and YouTube.

View source version on businesswire.com:https://www.businesswire.com/news/home/20240724236092/en/

CONTACT: Zach Bader

Vice President, Business Development

(913) 333-3000

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA KANSAS

INDUSTRY KEYWORD: BIOTECHNOLOGY TECHNOLOGY FDA HEALTH PHARMACEUTICAL HEALTH TECHNOLOGY RESEARCH SOFTWARE ARTIFICIAL INTELLIGENCE SCIENCE CLINICAL TRIALS

SOURCE: Dr. Vince Clinical Research (DVCR)

Copyright Business Wire 2024.

PUB: 07/24/2024 09:00 AM/DISC: 07/24/2024 09:01 AM

http://www.businesswire.com/news/home/20240724236092/en